Literature DB >> 2717608

Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.

H Robbins1, C H Zhang.   

Abstract

It is shown that, under certain assumptions, one can estimate the difference between the effect of a treatment and that of a placebo even when the treatment has been given to all and only those patients who are at risk (as evidenced by a screening examination).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717608      PMCID: PMC287052          DOI: 10.1073/pnas.86.9.3003

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  1 in total

1.  Estimating a treatment effect under biased sampling.

Authors:  H Robbins; C H Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

  1 in total
  3 in total

1.  Efficiency of the u,v method of estimation.

Authors:  H Robbins; C H Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples.

Authors:  M O Finkelstein; B Levin; H Robbins
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

3.  Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal.

Authors:  M O Finkelstein; B Levin; H Robbins
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.